PHASE I FEASIBILITY TRIAL ON A BIWEEKLY SCHEDULE OF CARBOPLATIN AND GEMCITABINE AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC NON-SMALL-CELL LUNG CANCER

被引：0
|
作者：
Mancuso, Andrea [1 ]
Migliorino, Maria Rita [1 ]
Martelli, Olga [1 ]
Belli, Raffaele [1 ]
Di Molfetta, Michele [1 ]
De Petris, Luigi [1 ]
Di Salvia, Roberto [1 ]
De Marinis, Filippo [2 ]
机构：
[1] Forlanini Hosp, Dept Resp Dis, Pneumooncol Unit 5, Rome, Italy
[2] Fdn Canc Res FoRO ONLUS, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [1] A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC).
    Mancuso, A
    Migliorino, MR
    Martelli, O
    Belli, R
    Di Molfetta, M
    De Petris, L
    Di Salvia, R
    De Marinis, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [2] EFFICACY AND FEASIBILITY OF GEMCITABINE AND CARBOPLATIN AS FIRST-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Lim, K.
    Lee, W.
    Kim, K.
    Lee, H.
    Han, S.
    Song, S.
    Kim, W. J.
    Lee, S.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (06) : S70 - S70
  • [3] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Lim, Kyu-Hyoung
    Lee, Hui-Young
    Song, Seo-Young
    CHINESE MEDICAL JOURNAL, 2013, 126 (24) : 4644 - 4648
  • [4] Efficacy and feasibility of gemcitabine and carboplatin as first-line chemotherapy in elderly patients with advanced non-small cell lung cancer
    Kyu-Hyoung Lim
    Hui-Young Lee
    Seo-Young Song
    中华医学杂志（英文版）, 2013, 126 (24) : 4644 - 4648
  • [5] Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer
    M. Ichiki
    R. Gohara
    R. Fujiki
    S. Hoashi
    T. Rikimaru
    H. Aizawa
    Cancer Chemotherapy and Pharmacology, 2003, 52 : 67 - 72
  • [6] Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer
    Ichiki, M
    Gohara, R
    Fujiki, R
    Hoashi, S
    Rikimaru, T
    Aizawa, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 52 (01) : 67 - 72
  • [7] Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer
    Lorusso, V
    Carpagnano, F
    Frasci, G
    Panza, N
    Di Rienzo, G
    Cisternino, ML
    Napoli, G
    Orlando, S
    Cinieri, S
    Brunetti, C
    Palazzo, S
    De Lena, M
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (02) : 405 - 411
  • [8] Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer
    Lorusso, V
    Crucitta, E
    Panza, N
    Silvestris, N
    Guida, M
    Carpagnano, F
    Mancarella, S
    Sambiasi, D
    De Lena, M
    ANNALS OF ONCOLOGY, 2002, 13 (12) : 1862 - 1867
  • [9] Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    Xu, N.
    Shen, P.
    Zhang, X. C.
    Yu, L. F.
    Bao, H. Y.
    Shi, G. M.
    Huang, S.
    Chen, J.
    Mou, H. B.
    Fang, W. J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 1 - 7
  • [10] Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer
    N. Xu
    P. Shen
    X. C. Zhang
    L. F. Yu
    H. Y. Bao
    G. M. Shi
    S. Huang
    J. Chen
    H. B. Mou
    W. J. Fang
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 1 - 7
12345